Physician profile
Peter C Wang
NPI 1063475242
$85,065.00
in general payments reported to CMS, 2019-2025
16 companies · $33K in 2025
The $33K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $5,135 · 2021: $7,227 · 2022: $6,352 · 2023: $12K · 2024: $4,995 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Consulting Fee: $14K · Education: $14K · Food and Beverage: $3,821 · Honoraria: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,472.04 |
| Consulting Fee | $14,000.00 |
| Education | $14,000.00 |
| Food and Beverage | $3,820.66 |
| Honoraria | $520.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $60,125.85 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $18,941.45 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $3,161.32 | 2019-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $869.76 | 2019-2020 | |
| Becton, Dickinson and Company | $649.05 | 2023-2025 | Phasix Mesh |
| Gilead Sciences, INC. | $358.99 | 2023-2025 | Vemlidy |
| Medtronic, INC. | $345.72 | 2021-2024 | Signia, Progrip |
| Covidien Lp | $166.69 | 2019 | |
| Organogenesis INC. | $124.51 | 2023 | Puraply |
| Abbvie INC. | $124.31 | 2025 | |
| Ethicon US, LLC | $65.34 | 2019-2023 | Surgicel Nu-Knit, Enseal, Harmonic |
| Conmed Corporation | $53.62 | 2019 | |
| Baxter Healthcare | $27.72 | 2020 | |
| Medtronic USA, INC. | $17.54 | 2019 | |
| Integra Lifesciences Corporation | $17.51 | 2023 | Integra, Omnigraft, Surgimend |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.